| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/07/2002 | WO2002018422A1 Amino acid substitution mutants of interleukin 13 |
| 03/07/2002 | WO2002018419A2 Nucleotide sequences which code for the ccpa1 gene |
| 03/07/2002 | WO2002018409A1 Antisense modulation of hpk/gck-like kinase expression |
| 03/07/2002 | WO2002018288A1 Method for obtaining a surface activation of a solid support for building biochips microarrays |
| 03/07/2002 | WO2002017953A2 Thrombomodulin analogs for use in recovery of signal cord injury |
| 03/07/2002 | WO2002017949A2 Novel functions for dp214 |
| 03/07/2002 | WO2002017948A2 Control of crop pests and animal parasites through direct neuronal uptake |
| 03/07/2002 | WO2002017947A2 Use of t proteins for the differential characterization and treatment of lesions and tumors of the nervous system |
| 03/07/2002 | WO2002017902A1 Gene conferring resistance to the antibacterial 4,5-dihydroxy-2-cyclopenten-1-one (dhcp), the protein encoded by same, and applications thereof |
| 03/07/2002 | WO2002017899A2 Regulation of angiogenesis via modulation of edg receptor mediated signal transduction comprising sphingosine-1-phosphate administration |
| 03/07/2002 | WO2002017858A2 Role of fosb in bone formation |
| 03/07/2002 | WO2002017856A2 Compositions and methods relating to hypertension |
| 03/07/2002 | WO2002017852A2 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers |
| 03/07/2002 | WO2002017711A2 Therapeutics and diagnostics based on a novel signal transduction system in platelets |
| 03/07/2002 | WO2001094420B1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 03/07/2002 | WO2001090415A3 Method of producing a dna library using positional amplification |
| 03/07/2002 | WO2001090408A3 Method for detecting and characterising activity of proteins involved in lesion and dna repair |
| 03/07/2002 | WO2001088165A8 Nucleotide sequences coding for signal transduction components involved in plant pathogen defence |
| 03/07/2002 | WO2001085915A3 Identifying clusters of transcription factor binding sites |
| 03/07/2002 | WO2001080810A9 Chondroitin synthase gene and methods of making and using same |
| 03/07/2002 | WO2001079269A3 Lipid binding protein 4 |
| 03/07/2002 | WO2001078757A3 Reversible immortalization |
| 03/07/2002 | WO2001077181A3 Anti-rhesus d monoclonal antibodies |
| 03/07/2002 | WO2001074855A3 Compositions and methods for dendritic cell-based immunotherapy |
| 03/07/2002 | WO2001070970A3 Regulation of human opsin-related g protein-coupled receptor |
| 03/07/2002 | WO2001068865A3 Fish vaccine against piscirickettsia salmonis |
| 03/07/2002 | WO2001068856A3 Human transcription factor-like protein and nucleic acids encoding same |
| 03/07/2002 | WO2001068840A3 REGULATION OF HUMAN DIAZEPAM BINDING INHIBITOR/ACYL-CoA-LIKE PROTEIN |
| 03/07/2002 | WO2001068703A8 Human histamine h3 gene variant-2 |
| 03/07/2002 | WO2001068122A3 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity 'mia' |
| 03/07/2002 | WO2001066738A3 Nucleic acids, encoding human crsp1 and uses thereof |
| 03/07/2002 | WO2001066710A3 Human ribonuclease |
| 03/07/2002 | WO2001064887A3 32705, 23224, 27423, 32700, 32712, novel human g-proteins |
| 03/07/2002 | WO2001064872A3 Gene 2465: methods and compositions for the diagnosis and treatment of cardiovascular, hepatic and bone disease |
| 03/07/2002 | WO2001064838A3 Thermophilic dna polymerases from thermoactinomyces vulgaris |
| 03/07/2002 | WO2001062936A3 Bunyaviridal reaper proteins and uses therefor |
| 03/07/2002 | WO2001062788A3 Corneodesmosin based test and model for inflammatory disease |
| 03/07/2002 | WO2001060997A3 Male tissue-specific regulatory region and method of using same |
| 03/07/2002 | WO2001060983A3 Treatment for bone disorders |
| 03/07/2002 | WO2001059155A3 Interferon-alpha induced genes |
| 03/07/2002 | WO2001059130A3 Proteins producing an altered immunogenic response and methods of making and using the same |
| 03/07/2002 | WO2001059114A3 Tumor suppressor gene, p47ing3 |
| 03/07/2002 | WO2001058956A3 Antibodies that bind human interleukin-18 and methods of making and using |
| 03/07/2002 | WO2001058949A3 Heterologous polypeptide of the tnf family |
| 03/07/2002 | WO2001058939A3 Novel invertase inhibitors and methods of use |
| 03/07/2002 | WO2001057233A3 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides |
| 03/07/2002 | WO2001057220A3 Human enzymes and polynucleotides encoding the same |
| 03/07/2002 | WO2001057219A3 Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods |
| 03/07/2002 | WO2001057201A3 Root transcriptional factors and methods of use |
| 03/07/2002 | WO2001055178A3 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 03/07/2002 | WO2001055174A3 Universal procedure for refolding recombinant proteins |
| 03/07/2002 | WO2001053501A3 Glutathione-s-transferase nucleic acids and polypeptides and methods of use thereof |
| 03/07/2002 | WO2001053493A3 Human kinase protein and polynucleotides encoding the same |
| 03/07/2002 | WO2001053468A3 Lipid metabolism enzymes and polynucleotides encoding them |
| 03/07/2002 | WO2001052612A3 Method for isolating proteins or protein and nucleic acid associations, and resulting complexes of particles and proteins |
| 03/07/2002 | WO2001051636A3 Secreted proteins |
| 03/07/2002 | WO2001049842A3 Mutm orthologue and uses thereof |
| 03/07/2002 | WO2001046231A3 Polynucleotides and polypeptides encoded thereby |
| 03/07/2002 | WO2001044515A3 Apparatus for performing biological reactions |
| 03/07/2002 | WO2001042285A3 Extracellular matrix and cell adhesion proteins as well as genes encoding them |
| 03/07/2002 | WO2001040474A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/07/2002 | WO2001038533B1 G protein-coupled receptor-like receptors and modulators thereof |
| 03/07/2002 | WO2001038360A3 Novel hcv non-structural polypeptide |
| 03/07/2002 | WO2001037194A3 Crystallizable compositions comprising a caspase-7 |
| 03/07/2002 | WO2001036686A3 Genomic polymorphism for predicting therapeutic response |
| 03/07/2002 | WO2001034822A3 Control of post-transcriptional gene silencing in plants |
| 03/07/2002 | WO2001034774A3 Method for protection of mammalian cells by means of over-expressed g-2/m cell cycle coupler |
| 03/07/2002 | WO2001032888A3 Human transferase molecules |
| 03/07/2002 | WO2001032874A3 Polypeptides and nucleic acids encoding same |
| 03/07/2002 | WO2001031008A3 Human and rat fgf-20 genes and gene expression products |
| 03/07/2002 | WO2001031006A3 Serum amyloid a isoform from colostrum |
| 03/07/2002 | WO2001029220A3 Mage-a12 antigenic peptides and uses thereof |
| 03/07/2002 | WO2001029218A3 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 03/07/2002 | WO2001025460A3 Compositions and methods for plant genetic modification |
| 03/07/2002 | WO2001023539A3 Genes encoding sterol delta-15 reductase in plants |
| 03/07/2002 | WO2001021772A3 Methods and microorganisms for production of panto-compounds |
| 03/07/2002 | WO2001021654A3 Syk kinase-associated cell cycle proteins, compositions and methods of use |
| 03/07/2002 | WO2001019994A3 PLANT APOPTOSIS INDUCING FACTORS (AIFs) |
| 03/07/2002 | WO2001019870A3 Secreted soluble alpha2delta-2, alpha2delta-3, alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 03/07/2002 | WO2001016324A3 Methods and compositions of a novel serine protease inhibitor |
| 03/07/2002 | WO2001011086A3 Methods of screening for angiogenesis modulators |
| 03/07/2002 | WO2001011049A3 Methods and compositions concerning canine interleukin 5 |
| 03/07/2002 | WO2001007915A8 Layered device with capture regions for cellular analysis |
| 03/07/2002 | WO2001007575A3 Subtilisin protease variants having amino acid deletions and substitutions in defined epitope regions |
| 03/07/2002 | WO2000073344A9 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 03/07/2002 | WO2000056352A3 Reagents and methods useful for detecting diseases of the prostate |
| 03/07/2002 | US20020029395 Flowering locus T (FT) and genetically modified plants having delayed flower development |
| 03/07/2002 | US20020029394 Homologs of starch synthase DU1 |
| 03/07/2002 | US20020029392 Methods for enhancing disease resistance in plants |
| 03/07/2002 | US20020029391 Epitope-driven human antibody production and gene expression profiling |
| 03/07/2002 | US20020028926 Washing solution is fed into a tip containing the solid phase unidirectionally from head to end |
| 03/07/2002 | US20020028925 Hsv viral vector |
| 03/07/2002 | US20020028923 Computer based iterative processes for generating synthetic compounds with desired physical, chemical and/or bioactive properties |
| 03/07/2002 | US20020028922 Chemically modified oligonucleotide for site-directed mutagenesis |
| 03/07/2002 | US20020028919 Viricides, anticancer or antitumor agents |
| 03/07/2002 | US20020028915 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/07/2002 | US20020028914 Chimeric toxins for targeted therapy |
| 03/07/2002 | US20020028785 Telomerase resistance; anticancer agents |
| 03/07/2002 | US20020028784 Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences |
| 03/07/2002 | US20020028762 Medicament and method for treating renal disease |